Asymchem Historical Balance Sheet

002821 Stock

81.65 0.97 1.17%

Trend analysis of Asymchem Laboratories Tian balance sheet accounts such as Other Current Liab of 182.3 K, Total Current Liabilities of 1.9 B or Total Stockholder Equity of 18.4 B provides information on Asymchem Laboratories' total assets, liabilities, and equity, which is the actual value of Asymchem Laboratories to its prevalent stockholders. By breaking down trends over time using Asymchem Laboratories balance sheet statements, investors will see what precisely the company owns and what it owes to creditors or other parties at the end of each accounting year.

Cash Flow Balance Sheet Income Statement

Covid

Financial Statement Analysis is much more than just reviewing and examining Asymchem Laboratories latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Asymchem Laboratories is a good buy for the upcoming year.

Asymchem Laboratories Inventory

557.59 Million

Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Asymchem Laboratories Tian. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.

About Asymchem Balance Sheet Analysis

Balance Sheet is a snapshot of the financial position of Asymchem Laboratories at a specified time, usually calculated after every quarter, six months, or one year. Asymchem Laboratories Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of Asymchem Laboratories and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which Asymchem currently owns. An asset can also be divided into two categories, current and non-current.

Asymchem Laboratories Balance Sheet Chart

At present, Asymchem Laboratories' Total Assets are projected to increase significantly based on the last few years of reporting. The current year's Total Current Liabilities is expected to grow to about 1.9 B, whereas Other Current Liabilities is forecasted to decline to about 182.3 K.

Total Assets Other Current Liab Total Current Liabilities Total Stockholder Equity Accounts Payable

Total Assets

Total assets refers to the total amount of Asymchem Laboratories assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Asymchem Laboratories books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. The total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets.

Total Current Liabilities

Total Current Liabilities is an item on Asymchem Laboratories balance sheet that include short term debt, accounts payable, accrued salaries payable, payroll taxes payable, accrued liabilities and other debts. Total Current Liabilities of Asymchem Laboratories Tian are important to investors because some useful performance ratios such as Current Ratio and Quick Ratio require Total Current Liabilities to be accurate. The total amount of liabilities that a company is expected to pay within one year, including debts, accounts payable, and other short-term financial obligations.

Total Stockholder Equity

The total equity held by shareholders, calculated as the difference between a company's total assets and total liabilities. It represents the net value of the company owned by shareholders.

Accounts Payable

An accounting item on the balance sheet that represents Asymchem Laboratories obligation to pay off a short-term debt to its creditors. The accounts payable entry is usually reported under current liabilities. If accounts payable of Asymchem Laboratories are not paid within the agreed terms, the payables are considered to be in default, which may trigger a penalty or interest payment, or the revocation of additional credit from the supplier. Accounts payable may also be considered a source of cash, since they represent funds being borrowed from suppliers. Given these cash flow considerations, suppliers have a natural inclination to push for shorter payment terms, while creditors want to lengthen the payment terms. The amount a company owes to suppliers or vendors for products or services received but not yet paid for. It represents the company's short-term liabilities.

Most accounts from Asymchem Laboratories' balance sheet are interrelated and interconnected. However, analyzing balance sheet accounts one by one will only give a small insight into Asymchem Laboratories current financial condition. On the other hand, looking into the entire matrix of balance sheet accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Asymchem Laboratories Tian. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.

	2021	2022	2023	2024 (projected)
Other Current Liabilities	1.1B	1.6B	191.9K	182.3K
Total Assets	15.2B	18.2B	19.8B	20.8B

Other Current Liab Total Assets

Asymchem Laboratories balance sheet Correlations

	Total Assets	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Other Liab	Retained Earnings	Accounts Payable	Cash	Other Assets	Long Term Debt	Net Receivables	Inventory	Other Current Assets	Total Liab	Intangible Assets	Common Stock	Property Plant Equipment	Short Term Investments	Net Tangible Assets	Other Stockholder Equity	Total Current Assets	Non Current Assets Total	Non Currrent Assets Other	Non Current Liabilities Total	Short Long Term Debt	Short Term Debt
Total Assets		0.5	0.97	1.0	0.79	0.97	0.82	0.99	0.96	-0.3	0.98	0.82	0.75	0.98	0.99	0.92	0.99	0.93	1.0	0.98	1.0	0.93	0.92	0.92	-0.3	-0.69
Other Current Liab	0.5		0.67	0.48	0.62	0.35	0.77	0.44	0.55	0.12	0.63	0.85	0.86	0.64	0.54	0.39	0.43	0.42	0.46	0.41	0.52	0.58	0.13	0.54	0.01	0.22
Total Current Liabilities	0.97	0.67		0.96	0.85	0.89	0.91	0.96	0.97	-0.2	0.98	0.92	0.89	1.0	0.96	0.86	0.93	0.84	0.95	0.91	0.97	0.92	0.82	0.92	-0.16	-0.51
Total Stockholder Equity	1.0	0.48	0.96		0.78	0.98	0.81	0.99	0.95	-0.31	0.98	0.81	0.74	0.97	0.98	0.93	0.99	0.93	1.0	0.99	1.0	0.92	0.93	0.92	-0.31	-0.7
Other Liab	0.79	0.62	0.85	0.78		0.72	0.95	0.77	0.88	-0.06	0.84	0.91	0.83	0.85	0.84	0.78	0.78	0.65	0.77	0.69	0.78	0.9	0.64	0.92	-0.26	-0.24
Retained Earnings	0.97	0.35	0.89	0.98	0.72		0.73	0.94	0.9	-0.34	0.94	0.71	0.6	0.91	0.96	0.95	0.99	0.97	0.98	0.98	0.96	0.89	0.94	0.88	-0.46	-0.78
Accounts Payable	0.82	0.77	0.91	0.81	0.95	0.73		0.79	0.9	-0.03	0.89	0.98	0.92	0.9	0.86	0.78	0.79	0.69	0.8	0.73	0.82	0.91	0.62	0.91	-0.24	-0.2
Cash	0.99	0.44	0.96	0.99	0.77	0.94	0.79		0.96	-0.3	0.95	0.79	0.75	0.97	0.96	0.88	0.97	0.87	0.99	0.97	0.99	0.89	0.94	0.9	-0.18	-0.71
Other Assets	0.96	0.55	0.97	0.95	0.88	0.9	0.9	0.96		-0.25	0.96	0.88	0.83	0.98	0.97	0.91	0.94	0.8	0.95	0.89	0.95	0.91	0.87	0.92	-0.23	-0.58
Long Term Debt	-0.3	0.12	-0.2	-0.31	-0.06	-0.34	-0.03	-0.3	-0.25		-0.24	-0.05	-0.01	-0.22	-0.27	-0.33	-0.33	-0.31	-0.31	-0.33	-0.29	-0.17	-0.39	-0.18	0.14	0.47
Net Receivables	0.98	0.63	0.98	0.98	0.84	0.94	0.89	0.95	0.96	-0.24		0.9	0.82	0.98	0.98	0.93	0.97	0.91	0.97	0.94	0.98	0.94	0.84	0.93	-0.33	-0.57
Inventory	0.82	0.85	0.92	0.81	0.91	0.71	0.98	0.79	0.88	-0.05	0.9		0.97	0.91	0.86	0.73	0.78	0.69	0.8	0.74	0.83	0.9	0.58	0.89	-0.13	-0.17
Other Current Assets	0.75	0.86	0.89	0.74	0.83	0.6	0.92	0.75	0.83	-0.01	0.82	0.97		0.87	0.79	0.6	0.68	0.57	0.72	0.66	0.78	0.81	0.51	0.8	0.09	-0.1
Total Liab	0.98	0.64	1.0	0.97	0.85	0.91	0.9	0.97	0.98	-0.22	0.98	0.91	0.87		0.97	0.88	0.95	0.86	0.96	0.93	0.98	0.93	0.84	0.93	-0.19	-0.55
Intangible Assets	0.99	0.54	0.96	0.98	0.84	0.96	0.86	0.96	0.97	-0.27	0.98	0.86	0.79	0.97		0.92	0.98	0.91	0.98	0.96	0.98	0.93	0.89	0.93	-0.34	-0.63
Common Stock	0.92	0.39	0.86	0.93	0.78	0.95	0.78	0.88	0.91	-0.33	0.93	0.73	0.6	0.88	0.92		0.95	0.88	0.92	0.89	0.9	0.86	0.88	0.85	-0.59	-0.69
Property Plant Equipment	0.99	0.43	0.93	0.99	0.78	0.99	0.79	0.97	0.94	-0.33	0.97	0.78	0.68	0.95	0.98	0.95		0.95	0.99	0.98	0.98	0.92	0.93	0.91	-0.39	-0.73
Short Term Investments	0.93	0.42	0.84	0.93	0.65	0.97	0.69	0.87	0.8	-0.31	0.91	0.69	0.57	0.86	0.91	0.88	0.95		0.94	0.96	0.92	0.87	0.84	0.84	-0.49	-0.7
Net Tangible Assets	1.0	0.46	0.95	1.0	0.77	0.98	0.8	0.99	0.95	-0.31	0.97	0.8	0.72	0.96	0.98	0.92	0.99	0.94		0.99	1.0	0.92	0.93	0.92	-0.31	-0.72
Other Stockholder Equity	0.98	0.41	0.91	0.99	0.69	0.98	0.73	0.97	0.89	-0.33	0.94	0.74	0.66	0.93	0.96	0.89	0.98	0.96	0.99		0.98	0.9	0.93	0.88	-0.31	-0.75
Total Current Assets	1.0	0.52	0.97	1.0	0.78	0.96	0.82	0.99	0.95	-0.29	0.98	0.83	0.78	0.98	0.98	0.9	0.98	0.92	1.0	0.98		0.92	0.91	0.92	-0.24	-0.67
Non Current Assets Total	0.93	0.58	0.92	0.92	0.9	0.89	0.91	0.89	0.91	-0.17	0.94	0.9	0.81	0.93	0.93	0.86	0.92	0.87	0.92	0.9	0.92		0.8	0.99	-0.3	-0.44
Non Currrent Assets Other	0.92	0.13	0.82	0.93	0.64	0.94	0.62	0.94	0.87	-0.39	0.84	0.58	0.51	0.84	0.89	0.88	0.93	0.84	0.93	0.93	0.91	0.8		0.81	-0.3	-0.87
Non Current Liabilities Total	0.92	0.54	0.92	0.92	0.92	0.88	0.91	0.9	0.92	-0.18	0.93	0.89	0.8	0.93	0.93	0.85	0.91	0.84	0.92	0.88	0.92	0.99	0.81		-0.27	-0.46
Short Long Term Debt	-0.3	0.01	-0.16	-0.31	-0.26	-0.46	-0.24	-0.18	-0.23	0.14	-0.33	-0.13	0.09	-0.19	-0.34	-0.59	-0.39	-0.49	-0.31	-0.31	-0.24	-0.3	-0.3	-0.27		0.35
Short Term Debt	-0.69	0.22	-0.51	-0.7	-0.24	-0.78	-0.2	-0.71	-0.58	0.47	-0.57	-0.17	-0.1	-0.55	-0.63	-0.69	-0.73	-0.7	-0.72	-0.75	-0.67	-0.44	-0.87	-0.46	0.35

Click cells to compare fundamentals

Asymchem Laboratories Account Relationship Matchups

Asymchem Laboratories balance sheet Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	3.8B	7.2B	15.2B	18.2B	19.8B	20.8B
Other Current Liab	161.8M	423.7M	1.1B	1.6B	191.9K	182.3K
Total Current Liabilities	504.0M	928.6M	2.2B	2.2B	1.8B	1.9B
Total Stockholder Equity	3.0B	6.0B	12.6B	15.6B	17.5B	18.4B
Other Liab	209.2M	238.4M	295.6M	257.3M	295.9M	158.3M
Retained Earnings	1.7B	2.3B	3.3B	6.2B	7.8B	8.1B
Accounts Payable	267.0M	378.6M	551.9M	568.9M	453.6M	270.7M
Cash	435.3M	2.1B	6.2B	5.3B	7.1B	7.5B
Other Assets	144.8M	287.6M	541.6M	415.0M	477.2M	501.1M
Net Receivables	712.4M	986.1M	1.8B	2.5B	2.0B	2.1B
Inventory	448.8M	726.4M	1.4B	1.5B	945.3M	557.6M
Other Current Assets	36.5M	189.6M	457.5M	376.4M	182.1M	119.0M
Total Liab	713.2M	1.2B	2.5B	2.5B	2.3B	2.4B
Intangible Assets	121.8M	285.7M	374.1M	473.2M	465.6M	488.9M
Common Stock	231.3M	242.5M	263.0M	369.9M	425.4M	446.7M
Property Plant Equipment	1.6B	2.5B	3.7B	5.4B	6.2B	6.5B
Net Tangible Assets	2.9B	5.9B	12.4B	15.4B	17.8B	18.6B
Other Stockholder Equity	7.7M	3.4B	9.1B	15.3B	17.6B	18.4B
Total Current Assets	1.6B	4.0B	10.3B	11.9B	12.4B	13.0B
Non Current Assets Total	2.1B	3.1B	4.8B	6.4B	7.4B	3.7B
Non Currrent Assets Other	54.1M	169.5M	354.7M	237.1M	688.5M	722.9M
Non Current Liabilities Total	209.2M	238.4M	341.5M	367.2M	456.4M	270.1M
Common Stock Shares Outstanding	231.4M	242.5M	263.1M	370.0M	369.7M	304.5M
Net Invested Capital	3.0B	6.0B	13.0B	15.6B	17.5B	9.4B
Net Working Capital	1.1B	3.1B	8.1B	9.7B	10.6B	5.5B
Capital Stock	231.3M	242.5M	263.0M	369.9M	369.5M	312.9M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

V	Visa Class A
GOOG	Alphabet Inc Class C
GOOG	Alphabet Inc Class C

Other Information on Investing in Asymchem Stock

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Asymchem Historical Balance Sheet

Asymchem Laboratories Inventory

557.59 Million

About Asymchem Balance Sheet Analysis

Asymchem Laboratories Balance Sheet Chart

Total Assets

Total Current Liabilities

Total Stockholder Equity

Accounts Payable

Asymchem Laboratories balance sheet Correlations

Asymchem Laboratories Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Asymchem Laboratories balance sheet Accounts

Also Currently Popular

Other Information on Investing in Asymchem Stock

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Total Stockholder Equity	+ 1.0	Total Assets
Net Tangible Assets	+ 1.0	Total Assets
Total Current Assets	+ 1.0	Total Assets
Total Liab	+ 1.0	Total Current Liabilities
Net Tangible Assets	+ 1.0	Total Stockholder Equity
Total Current Assets	+ 1.0	Total Stockholder Equity

Short Term Debt	- 0.87	Non Currrent Assets Other
Short Term Debt	- 0.78	Retained Earnings
Short Term Debt	- 0.75	Other Stockholder Equity
Short Term Debt	- 0.73	Property Plant Equipment
Short Term Debt	- 0.72	Net Tangible Assets
Short Term Debt	- 0.71	Cash